Opko Health OPK
$1.57 −$0.04 (-2.48%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $1.57 +0.04%
Open$1.57
Prev close$1.61
Day range$1.55 – $1.62
Volume3.52M
Market cap$1.17B
P/E (TTM)–
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$65.41M+15.9% YoY
Operating profit-$31.41M+6.4% YoY
Net profit-$53.53M-347.5% YoY
Diluted EPS-$0.07-333.3% YoY
Free cash flow-$39.61M-4.8% YoY
Operating cash flow-$36.32M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin38.5%
Operating margin-27.7%
Net margin-22.6%
Return on equity-12.2%
Return on assets-7.6%
Return on invested capital-6.9%
Current ratio4.97
Liabilities / assets40.6%
Cash & investments$390.22M
Total debt$506.88M
Net cash (debt)-$116.66M
Where the revenue comes from
Quarter 2026/Q3
By business line
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $65.41M | $163.58M | $124.20M | $606.88M | $447.64M |
| Total Operating Revenue | $65.41M | $163.58M | $124.20M | $606.88M | $447.64M |
| Cost of Revenue | $23.35M | $83.56M | $78.44M | $400.94M | $331.73M |
| Gross Profit | $42.06M | $80.02M | $45.76M | $205.94M | $115.91M |
| Operating Expense | $73.47M | $105.06M | $96.77M | $424.93M | $215.98M |
| Selling and Admin Expenses | $24.84M | $52.92M | $48.61M | $223.00M | $153.47M |
| Research & Development | $32.18M | $33.17M | $29.20M | $124.03M | $33.69M |
| Depreciation & Amortization & Depletion | $16.46M | $18.97M | $18.97M | $77.89M | $28.83M |
| -Depreciation & Amortization | $16.46M | $18.97M | $18.97M | $77.89M | $28.83M |
| Operating Profit | -$31.41M | -$25.04M | -$51.02M | -$218.99M | -$100.07M |
| Net Non-Operating Interest Income (Expense) | -$10.57M | -$8.16M | -$7.93M | -$93.65M | -$6.73M |
| Non-Operating Interest Income | $2.88M | $3.22M | $3.01M | $14.81M | $4.70M |
| Non-Operating Interest Expense | $13.45M | $11.38M | $10.94M | $108.46M | $11.43M |
| Other Income (Expense) | $4.11M | $19.80M | -$2.01M | $71.27M | $103.50M |
| Gain on Sale of Security | $251,000.00 | -$65,000.00 | -$298,000.00 | -$429,000.00 | -$134,000.00 |
| Other Non-Operating Income (Expenses) | $3.86M | $1.80M | -$1.71M | -$29.88M | $2.06M |
| Pretax Profit | -$37.87M | -$13.40M | -$60.96M | -$241.36M | -$3.30M |
| Tax | -$7.31M | -$4.98M | -$6.11M | -$15.71M | $13.30M |
| $5.00M | $0.00 | $2,000.00 | $29,000.00 | $17,000.00 | |
| Net Profit | -$53.53M | -$8.42M | -$54.85M | -$225.68M | -$31.26M |
| Profit from Continuing Operations | -$35.56M | -$8.42M | -$54.85M | -$225.68M | -$16.62M |
| Net Income from Discontinuous Operations | -$17.98M | – | – | – | – |
| Net Income to Parent Company | -$53.53M | -$8.42M | -$54.85M | -$225.68M | -$31.26M |
| Net Income to Common Stockholders | -$53.53M | -$8.42M | -$54.85M | -$225.68M | -$31.26M |
| Basic EPS | -$0.07 | -$0.01 | -$0.07 | -$0.30 | -$0.04 |
| Diluted EPS | -$0.07 | -$0.01 | -$0.07 | -$0.30 | -$0.04 |
| Special Income (Charges) | – | $18.07M | – | $101.58M | $0.00 |
| -Gain on Sale of Property/Plant/Equipment | – | $18.07M | – | $101.58M | $0.00 |
| -Less:Restructuring and Mergern & Acquisition | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.88B | $1.83B | $1.86B | $1.93B | $1.93B |
| Total Current Assets | $806.28M | $500.24M | $535.36M | $581.88M | $581.88M |
| Cash and Cash Equivalents & Short-Term Investments | $390.22M | $300.76M | $341.88M | $369.07M | $369.07M |
| -Cash and Cash Equivalents | $390.22M | $300.76M | $341.88M | $369.07M | $369.07M |
| Receivables | $94.92M | $114.91M | $107.62M | $126.12M | $126.12M |
| -Accounts Receivable | $80.21M | $81.89M | $79.64M | $90.26M | $90.26M |
| -Taxes Receivable | $7.59M | $7.84M | $6.06M | $11.84M | $11.84M |
| -Other Receivables | $7.11M | $25.19M | $21.93M | $24.02M | $24.02M |
| Prepaid Assets | $12.43M | $12.87M | $11.71M | $12.70M | $12.70M |
| Inventory | $50.60M | $61.85M | $64.40M | $65.82M | $65.82M |
| Other Current Assets | $10.05M | $9.84M | $9.76M | $8.17M | $8.17M |
| Total Non-Current Assets | $1.07B | $1.33B | $1.32B | $1.35B | $1.35B |
| Net PPE | $101.91M | $115.43M | $118.39M | $120.86M | $120.86M |
| -Gross PPE | $101.91M | $115.43M | $118.39M | $246.47M | $246.47M |
| Investments and Advances | $44.50M | $40.21M | $10.53M | $14.17M | $14.17M |
| -Available for Sale Securities | $43.74M | $39.46M | $9.77M | $13.41M | $13.41M |
| -Long Term Equity Investment | $755,000.00 | $755,000.00 | $756,000.00 | $758,000.00 | $758,000.00 |
| Financial Assets | $0.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| Goodwill and Other Intangible Assets | $908.53M | $1.15B | $1.17B | $1.20B | $1.20B |
| -Goodwill | $317.36M | $481.52M | $482.27M | $484.29M | $484.29M |
| -Other Intangible Assets | $591.17M | $672.57M | $691.35M | $711.28M | $711.28M |
| Other Non-Current Assets | $19.04M | $19.49M | $18.90M | $19.47M | $19.47M |
| Total Liabilities | $764.08M | $645.29M | $652.19M | $663.99M | $663.99M |
| Total Current Liabilities | $162.36M | $149.37M | $148.38M | $146.68M | $146.68M |
| Payables | $56.89M | $56.47M | $48.81M | $44.70M | $44.70M |
| -Accounts Payable | $47.92M | $50.04M | $44.18M | $41.10M | $41.10M |
| -Total Tax Payable | $8.97M | $6.43M | $4.63M | $3.60M | $3.60M |
| Current Accrued Expenses | $38.22M | $35.55M | $36.30M | $39.45M | $39.45M |
| Short-Term Debt and Capital Lease Obligation | $21.92M | $22.96M | $22.26M | $22.86M | $22.86M |
| -Current Debt | $13.15M | $10.56M | $9.65M | $10.25M | $10.25M |
| -Current Capital Lease Obligation | $8.77M | $12.40M | $12.61M | $12.61M | $12.61M |
| Current Provisions | $5.71M | $5.43M | $5.79M | $5.90M | $5.90M |
| Other Current Liabilities | $9.42M | – | – | – | – |
| Total Non-Current Liabilities | $601.72M | $495.92M | $503.80M | $517.31M | $517.31M |
| Long Term Debt and Capital Lease Obligation | $493.73M | $375.13M | $374.67M | $373.92M | $373.92M |
| -Long Term Debt | $464.25M | $338.49M | $336.03M | $333.72M | $333.72M |
| -Long Term Capital Lease Obligation | $29.49M | $36.64M | $38.64M | $40.21M | $40.21M |
| Non-Current Deferred Liabilities | $96.67M | $108.23M | $114.56M | $126.24M | $126.24M |
| Employee Benefits | $0.00 | $1.18M | $3.19M | $5.54M | $5.54M |
| Other Non-Current Liabilities | $11.32M | $11.39M | $11.38M | $11.60M | $11.60M |
| Total Equity | $1.12B | $1.18B | $1.20B | $1.27B | $1.27B |
| Stockholders' Equity | $1.12B | $1.18B | $1.20B | $1.27B | $1.27B |
| Capital Stock | $7.43M | $7.76M | $7.85M | $7.90M | $7.90M |
| -Common Stock | $7.43M | $7.76M | $7.85M | $7.90M | $7.90M |
| Additional Paid-In Capital | $3.55B | $3.56B | $3.57B | $3.57B | $3.57B |
| Retained Earnings | -$2.41B | -$2.35B | -$2.35B | -$2.29B | -$2.29B |
| Less: Treasury Stock | $0.00 | -$2.36M | -$1.79M | -$3.18M | -$3.18M |
| Gains/Losses Not Affecting Retained Earnings | -$33.30M | -$28.39M | -$27.49M | -$21.02M | -$21.02M |
| -Accumulated Depreciation | – | – | – | -$125.62M | -$125.62M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$36.32M | -$43.50M | -$19.31M | -$178.54M | -$25.92M |
| Net cash flow from continuing operations | -$36.32M | -$43.50M | -$19.31M | -$178.54M | -$25.92M |
| Net Income from Continuing Operations | -$53.53M | -$8.42M | -$54.85M | -$225.68M | -$31.26M |
| Gain/Loss from Continuing Operations | $5.05M | -$45.19M | -$32,000.00 | -$72.15M | $33.27M |
| Depreciation & Depletion & Amortization | $22.73M | $22.41M | $22.20M | $91.63M | $22.37M |
| Deferred Tax | -$10.05M | -$6.27M | -$7.89M | -$15.00M | -$10.15M |
| Other Non-Cash Items | $2.85M | $2.69M | $2.57M | $71.49M | -$30.12M |
| Change in Working Capital | -$1.02M | -$8.61M | $12.02M | -$41.18M | -$12.13M |
| -Change in Receivables | $198,000.00 | -$2.39M | $9.53M | $30.21M | $6.71M |
| -Change in Inventory | -$1.95M | $2.84M | $191,000.00 | -$4.12M | $1.17M |
| -Change in Payables and Accrued Expense | $3.59M | -$2.94M | -$4.67M | -$62.06M | -$20.84M |
| -Change in Other Current Assets | -$2.82M | -$6.26M | $6.84M | -$5.40M | -$4.02M |
| -Change In Other Working Capital | -$30,000.00 | $136,000.00 | $126,000.00 | $178,000.00 | $4.84M |
| Net cash flow from investing | $11.30M | $15.54M | -$1.80M | $230.30M | -$2.05M |
| Net Cash Flow from Continuing Investing Activities | $11.30M | $15.54M | -$1.80M | $230.30M | -$2.05M |
| Capital Expenditure | -$2.79M | -$3.00M | -$1.83M | -$12.28M | -$2.67M |
| Net PPE Purchase and Sale | $49,000.00 | $148,000.00 | $33,000.00 | $287,000.00 | $93,000.00 |
| Net Business Purchase and Sale | $14.54M | $18.39M | $0.00 | $190.11M | $0.00 |
| Net Investment Purchase and Sale | $0.00 | $0.00 | $0.00 | $52.18M | $527,000.00 |
| Financing Cash Flow | $114.47M | -$13.03M | -$5.16M | -$118.06M | -$18.34M |
| Net Cash Flow from Continuing Financing Activities | $114.47M | -$13.03M | -$5.16M | -$118.06M | -$18.34M |
| Net Issuance Payments Of Debt | $126.02M | $333,000.00 | -$390,000.00 | -$70.76M | -$4.70M |
| Net Common Stock Issuance | -$10.63M | -$13.02M | -$4.77M | -$47.04M | -$13.51M |
| Proceeds from Stock Option Exercised | -$922,000.00 | -$339,000.00 | $0.00 | -$256,000.00 | -$133,000.00 |
| Ending Cash Balance | $403.22M | $314.43M | $355.57M | $382.74M | $382.74M |
| Net Change in Cash | $89.45M | -$40.99M | -$26.27M | -$66.30M | -$46.31M |
| Beginning Cash Balance | $314.43M | $355.57M | $382.74M | $445.62M | $428.87M |
| Effect of Exchange Rate Changes | -$663,000.00 | -$145,000.00 | -$908,000.00 | $3.43M | $174,000.00 |
| Free Cash Flow | -$39.61M | -$46.50M | -$21.14M | -$190.82M | -$28.59M |
No comments yet — be the first to weigh in on OPK.
Sign in to join the discussion.